44.1  1.035 (2.4%)		11-11 16:00
Open: 43.99 High: 44.1 Volume: 2,924		Pre. Close: 43.0655 Low: 43.29 Market Cap: 52(M)

Short term
Mid term
Targets	6-month :	53.2	1-year :	62.14
Resists	First :	45.54	Second :	53.2
Pivot price	43.65
Supports	First :	42.22	Second :	40.16
MAs	MA(5) :	43.14	MA(20) :	43.58
	MA(100) :	38	MA(250) :	36.93
MACD	MACD :	0.7	Signal :	1
%K %D	K(14,3) :	41.7	D(3) :	30
RSI	RSI(14): 58.7
52-week	High :	45.54	Low :	27.2

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ GNOM ] has closed below upper band by 36.0%. Bollinger Bands are 3.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	44.14 - 44.31	44.31 - 44.51
Low:	42.83 - 43.01	43.01 - 43.22
Close:	43.76 - 44.05	44.05 - 44.39

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Thu, 06 Nov 2025
Avoiding Lag: Real-Time Signals in (GNOM) Movement - news.stocktradersdaily.com

Fri, 31 Oct 2025
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool

Wed, 13 Aug 2025
7 Best Biotech ETFs to Buy Now - US News Money

Wed, 30 Jul 2025
The Next Big Theme: July 2025 - Global X ETFs

Thu, 30 Jan 2025
Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status - Nature

Fri, 22 Mar 2024
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment (NASDAQ:GNOM) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management - Global
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.